Mild Cognitive Disorder
10
2
2
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
20.0%
2 terminated out of 10 trials
60.0%
-26.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
Fisetin in Mild Alzheimer's Disease
Early Detection, Remote Augmented Reality Combined Rehabilitation Therapy, and Translational Therapy for Patients With Chronic Kidney Disease and Cognitive Disorder
Study on the Effect of Online Cognitive Training Doses on Cognitive Function in Individuals With Mild Cognitive Decline
Analysis of Motor Skills in Subjects Aged 55 and Over: the Role of Cognitive Abilities for Planning Movement.
Neurocognitive Study for the Aging-a Longitudinal Study With a Greek Cypriot Cohort
Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder
Behavioral Interventions to Prevent or Delay Dementia
Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients
A Treadmill Training Program Augmented by Virtual Reality to Decrease Fall Risk in Older Adults
Enhancing Cognitive and Neurobehavioral Functions After Repetitive Traumatic Brain Injuries (rTBI) in Retired NFL Players and Military Veterans.